JCIC Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67.3K Sell
590
-1,413
-71% -$166K 0.03% 53
2026
Q2
$328K Hold
2,003
– – 0.1% 50
2026
Q1
$328K Sell
2,003
-61
-3% -$9.38K 0.1% 50
2025
Q4
$359K Sell
2,064
-20
-1% -$3.65K 0.11% 45
2025
Q3
$300K Buy
+2,084
New +$255K 0.09% 46
2025
Q1
$173K Sell
2,271
-289
-11% -$22.1K 0.07% 51
2024
Q4
$177K Buy
2,560
+740
+41% +$53.3K 0.07% 48
2024
Q3
$133K Buy
+1,820
New +$134K 0.05% 52

Other funds holding INSM

JCIC Asset Management's INSM Position: Q3 2026 in Review

JCIC Asset Management reduced its Insmed (INSM) stake by 71% in Q3 2026, selling an estimated $166K and leaving 590 shares worth $67.3K. The position accounts for 0.03% of the portfolio, ranked #53.

JCIC Asset Management first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $359K in Q4 2025. 706 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • JCIC Asset Management held 590 shares of Insmed worth $67.3K as of Q3 2026.
  • JCIC Asset Management sold 1,413 Insmed shares in Q3 2026, an estimated $166K.
  • Insmed made up 0.03% of JCIC Asset Management's portfolio in Q3 2026, its #53 holding.
  • JCIC Asset Management first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • JCIC Asset Management's Insmed position peaked at $359K in Q4 2025.
  • 706 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on JCIC Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.